FARMINGDALE, N.Y.--(BUSINESS WIRE)--Misonix, Inc. (NASDAQ: MSON), a developer of ultrasonic medical device technology for the treatment of cancer and other chronic health conditions, today reported financial results for its fiscal year 2008 first quarter ended September 30, 2007.
Revenues for the three months ended September 30, 2007 were $10.5 million, a 9.2% increase when compared with revenues of $9.6 million for the same period in fiscal 2007. The increase is due to an increase in sales of medical device products of $468,000 to $5.3 million and an increase in laboratory and scientific products sales of $422,000 to $5.2 million.
